COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy (MoveDMD®)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02439216
Recruitment Status : Completed
First Posted : May 8, 2015
Last Update Posted : November 15, 2019
Information provided by (Responsible Party):
Catabasis Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 12, 2017
Actual Study Completion Date : August 2019
Certification/Extension First Submitted : January 17, 2018